Clinical trial
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
NCT02311881 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 960 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.